Peptide Program & Compounding Pharmacy FAQ

Yes. Compounding is federally legal under Sections 503A and 503B of the FD&C Act. 503A pharmacies compound patient-specific prescriptions based on a valid prescriber-patient relationship. 503B outsourcing facilities compound for office use under FDA oversight without requiring individual prescriptions at time of production — the administering provider writes the prescription at point of care. All Ventra pharmacy partners are licensed under one or both frameworks. Ventra operates as a practice development network — we connect practices to pharmacies but never compound, prescribe, or distribute.

An FDA-registered pharmacy that compounds medications based on individual patient-specific prescriptions. A valid prescriber-patient relationship is required. 503B outsourcing facilities operate differently — they compound for office use under FDA oversight without requiring individual prescriptions at time of production, but the administering provider writes the prescription at point of care.

Every order includes Certificate of Analysis, sterility testing results where applicable. Our member portal provides regulatory updates, consent templates, and staff training materials. We monitor the FDA, state boards, and NABP continuously so you don’t have to.

We monitor FDA bulk substance classifications continuously. If a product moves to Category 2 or is otherwise restricted, we immediately notify all members, remove it from the formulary, and provide patient transition guidance.

503A (Lane 2) is patient-specific compounding — each prescription is filled for a named patient. This is the route for practices using our telehealth prescriber network. 503B (Lane 1) is office-use compounding — your practice orders inventory in advance and administers on-site. This requires a prescriber on staff. Both lanes are fully supported through the Ventra network.

We offer two tiers: a free Partner Access tier with a one-time $250–$500 onboarding fee, and a premium Growth Partner tier at $499 per month. No long-term contracts. Cancel anytime with 30 days notice.

Premium tier is billed monthly at $499. Free tier members pay a one-time onboarding fee. Pharmacy orders are billed directly by the pharmacy at your competitive pharmacy rate. Telehealth script routing is $45 per script, billed monthly in arrears.

Most practices recoup their membership fee within their first 2–3 patient appointments. A practice seeing 20 peptide patients per month typically nets $5,000–$10,000 monthly after all costs. Results vary based on patient volume, pricing, and market conditions. Visit our Revenue page for the interactive calculator.

No long-term contracts. Month-to-month membership. We believe if the network isn’t delivering value, you shouldn’t be locked in. 30 days notice to cancel.

This depends on your model. Most practices charge patients directly for their services (consultation + treatment), and the pharmacy bills the practice at wholesale. Some practices use a drop-ship model where the pharmacy ships to the patient. We support both.

Yes. All compounded medications through the Ventra network are cash-pay. We do not process insurance claims, which keeps the model simple and keeps your practice outside federal insurance billing requirements.

Partner Access is our free tier — you get pharmacy network access, formulary pricing, and basic compliance templates for a one-time $250–$500 onboarding fee with no monthly cost. Growth Partner at $499/mo adds telehealth prescriber access, monthly marketing strategy calls, social media and email templates, patient education materials, Google Business Profile optimization, ongoing compliance monitoring, quarterly audits, and priority support.

No. Ventra maintains a zero-PHI architecture. Patient data flows directly between your practice, the telehealth provider, and the pharmacy. Ventra never accesses, stores, or transmits protected health information.

Most practices complete onboarding within 48 hours and can place their first patient order immediately after.

We work with med spas, IV therapy lounges, functional medicine clinics, integrative health practices, weight loss clinics, chiropractic offices, primary care practices, naturopathic clinics, and any licensed wellness practice looking to add peptide or GLP-1 services. If you serve patients in a clinical setting, you likely qualify.

You can contact a pharmacy directly — but you’ll negotiate pricing alone, build your own compliance infrastructure, source your own telehealth prescribers, create your own consent forms, and monitor FDA regulatory changes yourself. Ventra bundles all of that into one network: pre-negotiated pharmacy pricing, built-in telehealth prescriber access, compliance documentation, marketing support, and real-time regulatory updates. Most practices find the network saves them dozens of hours and reduces compliance risk significantly.